Clinical Trial Update: Clinical Study Evaluating Vildagliptin Versus Vildagliptin/Metformin on NAFLD With DM [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating vildagliptin alone versus vildagliptin with metformin in patients with diabetes and suspected nonalcoholic fatty liver disease (NAFLD).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Nonalcoholic Fatty Liver Disease

Drugs mentioned

• Vildagliptin (vildagliptin)
• Vildagliptin/metformin (vildagliptin/metformin)

Snippet

Sponsor: Sherief Abd-Elsalam | Conditions: dm | Phase 3 | Status: RECRUITING